An Investigator Initiated Open-Label Controlled Randomized Study of Alefacept Treatment Prevention of Graft Versus Host Disease in Myeloablative Stem Cell Transplantation.

Status: Discontinued

Phase of Trial: Phase III

Latest Information Update: 23 Apr 2015

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

20 Apr 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov
21 Oct 2010 Planned end date changed from 1 Jul 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov.
05 Oct 2009 Study design changed from open to double-blind, according to ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com